Yu C. Zhang
Nantong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma.
ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: March 07, 2025
Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway.
Journal: International journal of immunopathology and pharmacology
Published: April 28, 2024
Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion.
Journal: Cytokine
Published: December 24, 2023
Tumor cell-derived LC3B+extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90α-IL-6/IL-8 signaling axis.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 01, 2023
Radiomics Based on Contrast-Enhanced CT for Recognizing c-Met-Positive Hepatocellular Carcinoma: a Noninvasive Approach to Predict the Outcome of Sorafenib Resistance.
Journal: Molecular imaging and biology
Published: July 30, 2023
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: March 30, 2023
Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
Journal: Frontiers in immunology
Published: January 05, 2023
An automatic and accurate deep learning-based neuroimaging pipeline for the neonatal brain.
Journal: Pediatric radiology
Published: October 20, 2022
CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Journal: International journal of general medicine
Published: February 18, 2022
Evaluation of plasma LC3B+extracellular vesicles as a potential novel diagnostic marker for hepatocellular carcinoma.
Journal: International immunopharmacology
Published: January 06, 2022
URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma.
Journal: OncoTargets and therapy
Published: April 23, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026